BEDMINSTER, N.J.--(BUSINESS WIRE)--EKR Therapeutics, Inc., a specialty pharmaceutical company focused on acquiring, developing, and commercializing novel acute-care products, today announced the appointment of Dave Iwanicki as Senior Vice President, Corporate Development.
